107 related articles for article (PubMed ID: 9190888)
1. Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo.
Yuan R; Sumi M; Benet LZ
J Pharmacol Exp Ther; 1997 Jun; 281(3):1499-505. PubMed ID: 9190888
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of nitroglycerin induced blood vessel relaxation in chronic renal failure model rats.
Kurata N; Nakamura S; Mizumura J; Sumi M; Nishimura Y; Yamamoto T; Yasuhara H
Res Commun Mol Pathol Pharmacol; 1999; 106(1-2):23-36. PubMed ID: 11127805
[TBL] [Abstract][Full Text] [Related]
3. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
4. Effect of dexamethasone treatment on the biotransformation of glyceryl trinitrate: cytochrome P450 3A1 mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
McDonald BJ; Monkewich GJ; Long PG; Anderson DJ; Thomas PE; Bennett BM
Can J Physiol Pharmacol; 1994 Dec; 72(12):1513-20. PubMed ID: 7736342
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochromes P450 3A in mouse lung: effects of dexamethasone and pregnenolone 16alpha-carbonitrile.
Haag M; Fautrel A; Guillouzo A; Frossard N; Pons F
Arch Toxicol; 2003 Mar; 77(3):145-9. PubMed ID: 12632254
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
Lin JH; Chiba M; Chen IW; Nishime JA; deLuna FA; Yamazaki M; Lin YJ
Drug Metab Dispos; 1999 Oct; 27(10):1187-93. PubMed ID: 10497146
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of tissue thiols content from nitroglycerin-induced cyclic-3',5'-guanosine monophosphate and the state of tolerance: in vivo experiments in rats.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1995 Apr; 273(1):94-100. PubMed ID: 7714819
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
9. Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
Bennett BM; McDonald BJ; St James MJ
J Pharmacol Exp Ther; 1992 May; 261(2):716-23. PubMed ID: 1349646
[TBL] [Abstract][Full Text] [Related]
10. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
11. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
14. Rabbit aorta glutathione S-transferases and their role in bioactivation of trinitroglycerin.
Singhal SS; Piper JT; Srivastava SK; Chaubey M; Bandorowicz-Pikula J; Awasthi S; Awasthi YC
Toxicol Appl Pharmacol; 1996 Oct; 140(2):378-86. PubMed ID: 8887455
[TBL] [Abstract][Full Text] [Related]
15. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
16. [Involvement of cytochrome P4503A in the monohydroxylation of ring A of praziquantel in rat liver microsomes].
Zhang YJ; Quan YZ
Yao Xue Xue Bao; 1997; 32(1):5-10. PubMed ID: 11243219
[TBL] [Abstract][Full Text] [Related]
17. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
18. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
Sarver JG; Bachmann KA; Zhu D; Klis WA
Drug Metab Dispos; 1998 Jan; 26(1):78-82. PubMed ID: 9443857
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
